Upregulation of CD44 protein expression in HNSCC tumor samples (median: 0.003) compared with normal subjects (median: –1.3); statistically significant (p = 0.0008;Fig. 1). This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.